XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies. The Company’s expanding pipeline includes XOMA 052, an anti-IL-1 beta antibody, and XOMA 629, a synthetic peptide compound derived from bactericidal/permeability-increasing protein. XOMA’s proprietary development pipeline is primarily funded by multiple revenue streams resulting from the licensing of its antibody technologies, product … Continue reading XOMA (US) LLC
Translational Bioscience caters expert solutions to pharma/biotech companies aiding the development of novel therapeutics. Located in the Biotech Bay area Translational Bioscience was founded by a team of successful entrepreneurs, experienced scientists, and proven industry leaders.